BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 20878980)

  • 1. Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer.
    Sanchez-Palencia A; Gomez-Morales M; Gomez-Capilla JA; Pedraza V; Boyero L; Rosell R; Fárez-Vidal ME
    Int J Cancer; 2011 Jul; 129(2):355-64. PubMed ID: 20878980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cDNA microarray analysis of gene expression in pathologic Stage IA nonsmall cell lung carcinomas.
    Nakamura H; Saji H; Ogata A; Hosaka M; Hagiwara M; Saijo T; Kawasaki N; Kato H
    Cancer; 2003 Jun; 97(11):2798-805. PubMed ID: 12767093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma.
    Hamamoto J; Soejima K; Yoda S; Naoki K; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Yasuda H; Hayashi Y; Sakamoto M; Takebayashi T; Betsuyaku T
    Mol Med Rep; 2013 Aug; 8(2):456-62. PubMed ID: 23759980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Expression Pattern of THBS1 and THBS2 in Lung Cancer: Clinical Outcome and a Systematic-Analysis of Microarray Databases.
    Weng TY; Wang CY; Hung YH; Chen WC; Chen YL; Lai MD
    PLoS One; 2016; 11(8):e0161007. PubMed ID: 27513329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
    Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
    J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein expression profiles of non-small cell lung carcinomas: correlation with histological subtype.
    Volm M; Koomägi R; Efferth T; Mattern J
    Anticancer Res; 2002; 22(4):2321-4. PubMed ID: 12174921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung.
    Raponi M; Zhang Y; Yu J; Chen G; Lee G; Taylor JM; Macdonald J; Thomas D; Moskaluk C; Wang Y; Beer DG
    Cancer Res; 2006 Aug; 66(15):7466-72. PubMed ID: 16885343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomewide DNA methylation analysis identifies novel methylated genes in non-small-cell lung carcinomas.
    Carvalho RH; Hou J; Haberle V; Aerts J; Grosveld F; Lenhard B; Philipsen S
    J Thorac Oncol; 2013 May; 8(5):562-73. PubMed ID: 23524404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of lymph node metastasis by analysis of gene expression profiles in non-small cell lung cancer.
    Takada M; Tada M; Tamoto E; Kawakami A; Murakawa K; Shindoh G; Teramoto K; Matsunaga A; Komuro K; Kanai M; Fujiwara Y; Shirata K; Nishimura N; Miyamoto M; Okushiba S; Kondo S; Hamada J; Katoh H; Yoshiki T; Moriuchi T
    J Surg Res; 2004 Nov; 122(1):61-9. PubMed ID: 15522316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression signatures in lung cancer reveal a profile for EGFR-mutant tumours and identify selective PIK3CA overexpression by gene amplification.
    Angulo B; Suarez-Gauthier A; Lopez-Rios F; Medina PP; Conde E; Tang M; Soler G; Lopez-Encuentra A; Cigudosa JC; Sanchez-Cespedes M
    J Pathol; 2008 Feb; 214(3):347-56. PubMed ID: 17992665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive lung cancer determined by expression profiling and transcriptional regulation.
    Han N; Dol Z; Vasieva O; Hyde R; Liloglou T; Raji O; Brambilla E; Brambilla C; Martinet Y; Sozzi G; Risch A; Montuenga LM; ; Brass A; Field JK
    Int J Oncol; 2012 Jul; 41(1):242-52. PubMed ID: 22469662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
    Staaf J; Isaksson S; Karlsson A; Jönsson M; Johansson L; Jönsson P; Botling J; Micke P; Baldetorp B; Planck M
    Int J Cancer; 2013 May; 132(9):2020-31. PubMed ID: 23023297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of DUSP6 with expression of ERK and Ki-67 in non-small cell lung carcinoma.
    Lee H; Kim JM; Huang SM; Park SK; Kim DH; Kim DH; Lee CS; Suh KS; Yi ES; Kim KH
    Pathol Res Pract; 2011 Jul; 207(7):428-32. PubMed ID: 21680106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S; Fields CR; Su N; Pan YX; Robertson KD
    Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
    Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
    Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling for early-stage NSCLC.
    Petrosyan F; Daw H; Haddad A; Spiro T; Sood R
    Am J Clin Oncol; 2015 Feb; 38(1):103-7. PubMed ID: 23608827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
    Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
    Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity (LOH) in non-small cell lung cancer: difference between adenocarcinoma and squamous cell carcinoma.
    Yoshino I; Osoegawa A; Yohena T; Kameyama T; Oki E; Oda S; Maehara Y
    Respir Med; 2005 Mar; 99(3):308-12. PubMed ID: 15733506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.